Max B. Mitchell, MD The Journal of Thoracic and Cardiovascular Surgery

Slides:

Advertisements

Similar presentations

Of mice and men and surgical transcatheter aortic valve insertion

Advertisements

Lost in translation The Journal of Thoracic and Cardiovascular Surgery

Manuel J. Antunes, MD, PhD, DSc

Surgery for congenital diseases of the aorta

Murray H. Kwon, MD The Journal of Thoracic and Cardiovascular Surgery

Centers for Disease Control “increased-risk” organ donor: Not so risky? Francis D. Pagani, MD, PhD The Journal of Thoracic and Cardiovascular Surgery

Form ever follows function

Application of a neuroscience research model to study neuroprotection in children with congenital heart disease Nobuyuki Ishibashi, MD, Richard A. Jonas,

Functional mitral stenosis after mitral valve repair is a true anatomic problem that originates from the time of surgery Vincent Chan, MD, MPH, Thierry.

New treatment approaches create new disease processes: A short guide on how to reduce unexpected events to a minimum Martin Czerny, MD, MBA The Journal.

Bicuspid aortic valve aortopathy: One size fits all?

Surgeons, valve repair in severely unbalanced atrioventricular septal defect, and the emperor's new clothes David M. Overman, MD The Journal of Thoracic.

The lord of the rings Antonio Miceli, MD, PhD

The variability of the mitral valve anatomy and terminology

Aditya K. Kaza, MD The Journal of Thoracic and Cardiovascular Surgery

Support Your Specialty

Transcatheter aortic valve replacement in intermediate-risk patients

Innovation and science: The future of valve design

It's not “just a shunt” but sometimes it should be…

Do we need a bibliometrician to know which way the wind is blowing?

A first start for lung transplantation?

Transcatheter aortic valve replacement and surgical aortic valve replacement: Both excellent therapies J. James Edelman, MBBS(Hons), PhD, Vinod H. Thourani,

Get it right the first time

Torsten Doenst, MD, PhD, Markus Richter, MD

Fenton H. McCarthy, MD, MS, Nimesh D. Desai, MD, PhD

Fraser Douglas Rubens, MD

Sinus of Valsalva aneurysms: Stabilizing the repair destabilizing the aortic valve? M. Sertaç Çiçek, MD, FACC The Journal of Thoracic and Cardiovascular.

Niv Ad, MD, Lawrence M. Wei, MD

The Journal of Thoracic and Cardiovascular Surgery

In search of the smoking gun in calcific aortic valve disease

Replicating the success of mitral valve repair in the aortic valve

Is endoluminal vacuum therapy “sponge worthy”?

Commentary: Ongoing advancements in the understanding of tricuspid valve dynamics and functional geometry Daniel J.P. Burns, MD, MPhil The Journal of.

Taking UP the chronic pulmonary obstructive disease gauntlet

Passing the torch The Journal of Thoracic and Cardiovascular Surgery

Sutureless valve implantation: Every detail counts

Biomaterials for heart valve replacement: Conjectures and refutations

Prognosis and “granularity”: Building on staging foundations?

Who is your plastic surgeon

Shunt right or left? Decision 2016

Warfarin or aspirin after mitral valve repair: Why work harder?

T. Brett Reece, MD The Journal of Thoracic and Cardiovascular Surgery

Hans-Joachim Schäfers, MD

The origins of open heart surgery at the University of Minnesota 1951 to 1956 Richard A. DeWall, MD The Journal of Thoracic and Cardiovascular Surgery

Early extubation after cardiac surgery: The evolution continues

The Journal of Thoracic and Cardiovascular Surgery

Discussion The Journal of Thoracic and Cardiovascular Surgery

Tissue valve, nitinol stent, or storage solution

The future of cardiac surgery training: A survival guide

Apparently, size matters…in congenital heart disease and brain injury

Hope should not spring eternal

Permanent pacemaker insertion following transcatheter aortic valve replacement: Not infrequent, not benign, and becoming predictable Craig M. Jarrett,

The continuing challenge of congenital heart disease in China

Bicuspid aortopathy: Seeing the forest for the trees

Ralph E. Delius, MD The Journal of Thoracic and Cardiovascular Surgery

The Robin Hood principle in the treatment of congenital heart disease: Taking technologic developments intended for adults and using it in kids Paul.

After neoadjuvant chemoradiation therapy, predicted pulmonary function may be reduced by 10% Benny Weksler, MD, MBA The Journal of Thoracic and Cardiovascular.

The Journal of Thoracic and Cardiovascular Surgery

“The more things change…”: The challenges ahead

Appropriate Use Criteria for coronary revascularization in patients with stable ischemic heart disease: What the surgeon needs to know Harold L. Lazar,

Sarcopenia and heart valve surgery

More than vital: Who bears the burden?

Respect the aorta The Journal of Thoracic and Cardiovascular Surgery

American College of Cardiology/American Heart Association 2016 dual antiplatelet therapy (DAPT) focused update: Implications for surgeons Richard J.

Preoperative PFTs: The answer is blowing in the wind

Of mice and men… The Journal of Thoracic and Cardiovascular Surgery

Journal changes and initiatives

Edward Y. Chan, MD, Michael J. Reardon, MD

Zone zero thoracic endovascular aortic repair is all about “location, location, location” Kevin L. Greason, MD The Journal of Thoracic and Cardiovascular.

Deciding how much to pay for effective care

Presentation transcript:

Pulmonary valve replacement for congenital heart disease: What valve substitute should we be using? Max B. Mitchell, MD The Journal of Thoracic and Cardiovascular Surgery Volume 152, Issue 5, Pages 1230-1232 (November 2016) DOI: 10.1016/j.jtcvs.2016.07.031 Copyright © 2016 The American Association for Thoracic Surgery Terms and Conditions

Max B. Mitchell, MD The Journal of Thoracic and Cardiovascular Surgery 2016 152, 1230-1232DOI: (10.1016/j.jtcvs.2016.07.031) Copyright © 2016 The American Association for Thoracic Surgery Terms and Conditions